Investors
Sofinnova Partners
https://sofinnovapartners.comSofinnova Partners is a Paris-based venture capital firm investing from seed to later growth stages. They focus on biotech, health tech, and robotics, supporting early to late-stage companies with varying check sizes. Their portfolio includes Bioptimus, Cure51, and Moon Surgical. Sofinnova Partners aims to foster technological advancements and innovation in life sciences and deep tech sectors.
Recent Investments
- Cure51Seed(
44 ) - deepcSeries A( 41 )
- May HealthSeries B( 52 )
- AsceneuronSeries C( 48 )
- BioptimusSeed( 52 )
- Disco PharmaceuticalsSeed( 41 )
- Myricx BioSeries A( 75 )
- KiroSeries A( 44 )
- BioCorteXSeed( 37 )
- Sitryx TherapeuticsSeries A( 41 )
- Tenpoint TherapeuticsSeries A( 48 )
- BrightHeartSeed( 37 )
- TissiumSeries D( 60 )
- Moon SurgicalSeries B( 60 )
- Alia TherapeuticsSeed( 26 )
- CorWaveSeries C( 52 )
- Bon VivantSeries A( 41 )
- Noema PharmaSeries B( 48 )
- Gradient Denervation TechnologiesSeries A( 44 )
- Amolyt PharmaSeries C( 48 )
- SensorionSeries B( 41 )
- MicrophytUnknown( 33 )
- Moon SurgicalSeries A( 60 )
- GFBiochemicalsSeries A( 37 )
- BiosyntiaSeries B( 37 )
- Elicit PlantSeries A( 33 )
- F2GUnknown( 48 )
- Mablink BioscienceSeries A( 41 )
- TissiumSeries C( 60 )
- Mainstay MedicalUnknown( 56 )
- SynthaceSeries C( 52 )
- NorthSea TherapeuticsSeries C( 56 )
- Micropep TechnologiesSeries A( 33 )
- SafeHealUnknown( 52 )
- Mnemo TherapeuticsSeries A( 60 )
- Muna TherapeuticsSeries A( 52 )
- GlycoEraSeries A( 44 )
- Noema PharmaUnknown( 48 )
- AlediaSeries D( 48 )
- Moon SurgicalSeed( 60 )
- EnginZymeSeries A( 48 )
- NorthSea TherapeuticsSeries B( 56 )
- Myricx PharmaSeed( 44 )
- TissiumSeries B( 60 )
- May HealthSeries A( 52 )
- AFYX TherapeuticsUnknown( 41 )
- Sphere FluidicsUnknown( 26 )
- AFYX TherapeuticsSeries A( 41 )
- ENYO PharmaSeries A( 52 )
- MISSION TherapeuticsSeries C( 48 )
- MISSION TherapeuticsSeries B( 48 )
- TissiumSeries A( 60 )
- MISSION TherapeuticsSeries A( 48 )
- Mainstay MedicalSeries A( 56 )